Phase III randomized double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting

Autor:	James S. Hardwick, Alexandra D. Carides, D. T. Chua, Anish Maru, Jørn Herrstedt, Fausto Roila, Suzanne DeVandry, Arlene Taylor, Judith A. Boice, Steven M. Grunberg
Rok vydání:	2010
Předmět:	Cisplatin Cancer Research Nausea business.industry Antagonist humanities Fosaprepitant Double blind study Ondansetron Oncology Anesthesia medicine Vomiting medicine.symptom business Dexamethasone medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:9021-9021
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.9021
Popis:	9021^ Background: Addition of a neurokinin-1 antagonist (NK1A) to a standard ondansetron (O) and dexamethasone (D) antiemetic regimen improves prevention of cisplatin-induced nausea/vomiting (CINV)...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ad56b903ec01a054a809ce113b0fe37c https://doi.org/10.1200/jco.2010.28.15_suppl.9021 Zobrazit plný text záznamu